Premium
Bicara Therapeutics Inc (BCAX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor... Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, or HNSCC, where there remains a significant unmet need. We intend to initiate a pivotal Phase 2/3 trial of ficerafusp alfa in combination with pembrolizumab as a first-line therapy in recurrent/metastatic HNSCC excluding HPV-positive patients with oropharyngeal squamous cell carcinoma late in the fourth quarter of 2024 or early in the first quarter of 2025. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.56 | 20.7792207792 | 12.32 | 14.93 | 11.765 | 289162 | 13.51172886 | CS |
| 4 | 1.04 | 7.51445086705 | 13.84 | 14.93 | 11.64 | 344334 | 13.03446568 | CS |
| 12 | -4.73 | -24.1203467619 | 19.61 | 20.7087 | 11.1 | 449993 | 14.86516921 | CS |
| 26 | -11.37 | -43.3142857143 | 26.25 | 27.95 | 11.1 | 412766 | 18.47209413 | CS |
| 52 | -11.37 | -43.3142857143 | 26.25 | 27.95 | 11.1 | 412766 | 18.47209413 | CS |
| 156 | -11.37 | -43.3142857143 | 26.25 | 27.95 | 11.1 | 412766 | 18.47209413 | CS |
| 260 | -11.37 | -43.3142857143 | 26.25 | 27.95 | 11.1 | 412766 | 18.47209413 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
